Clinical Trials Browser

Phase 2 × Not yet recruiting × Platinum-resistant Ovarian Cancer (PROC) × Clear all

NCT06600841 2024-09-19

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

Phase 2 Not yet recruiting

Platinum-resistant Ovarian Cancer (PROC)